Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia (Q44956444)

7 December 2017

Clinical and biological significance of CD56 antigen expression in acute promyelocytic leukemia (English)

1 reference

7 December 2017

1 reference

Shigeki Ito

1

1 reference

7 December 2017

Yoji Ishida

2

1 reference

7 December 2017

Tatsuo Oyake

3

1 reference

7 December 2017

Mamiko Satoh

4

1 reference

7 December 2017

Yusei Aoki

5

1 reference

7 December 2017

Shugo Kowata

6

1 reference

7 December 2017

Toshiyuki Uchiyama

7

1 reference

7 December 2017

Sanae Enomoto

8

1 reference

7 December 2017

Takeshi Sugawara

9

1 reference

7 December 2017

Hideharu Numaoka

10

1 reference

7 December 2017

Keijiro Suzuki

11

1 reference

7 December 2017

Kazunori Murai

12

1 reference

7 December 2017

1 September 2004

1 reference

7 December 2017

1 reference

7 December 2017

45

1 reference

7 December 2017

9

1 reference

7 December 2017

1783-1789

1 reference

Pathogenesis and management of acute promyelocytic leukemia

7 December 2017

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Acute promyelocytic leukemia: a curable disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

All-trans-retinoic acid in acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Clonal evolution of blasts in an elderly patient with CD56(+) relapsed acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Clinical and biological characteristics of acute promyelocytic leukemia in Taiwan: a high relapse rate in patients with high initial and peak white blood cell counts during all-trans retinoic acid treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Extramedullary involvement in patients with acute promyelocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Immunophenotype of adult and childhood acute promyelocytic leukaemia: correlation with morphology, type of PML gene breakpoint and clinical outcome. A cooperative Italian study on 196 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Light scatter and immunophenotypic characteristics of blast cells in typical acute promyelocytic leukemia and its variant

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): does it prove true for the M3-variant?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Flow cytometric analysis of aberrant antigen expression of blasts using CD45 blast gating for minimal residual disease in acute leukemia and high-risk myelodysplastic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

Clonal selection of CD56+ t(8;21) AML blasts: further suggestion of the adverse clinical significance of this biological marker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190410001683624

10.1080/10428190410001683624

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference